J. Goldman & CO LP Edwards Lifesciences Corp Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $358,013 - $478,782	-6,222 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $75,575 - $116,802	1,442 Added 30.17%	6,222 $1.17 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $2.22 Million - $2.54 Million	-30,942 Reduced 86.62%	4,780 $1.12 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $2.2 Million - $2.69 Million	35,722 New	35,722 $7.86 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.